Noninvasive photoacoustic identification of sentinel lymph nodes containing methylene blue in vivo in a rat model by Song, Kwang Hyun et al.
N
l
i
K
E
W
D
O
C
O
S
J
W
D
6
C
S
L
W
D
O
C
O
S
1
S
a
d
c
I
l

T
t
p
a
e
d
i
a
u
t
n
t
t
t
p
c
A
L
C
E
Journal of Biomedical Optics 135, 054033 September/October 2008
J
Downloaded Frooninvasive photoacoustic identification of sentinel
ymph nodes containing methylene blue in vivo
n a rat model
wang Hyun Song
rich W. Stein
ashington University in Saint Louis
epartment of Biomedical Engineering
ptical Imaging Laboratory
ampus Box 1097
ne Brookings Drive
aint Louis, Missouri 63130-4899
ulie A. Margenthaler
ashington University School of Medicine
epartment of Surgery
60 South Euclid
ampus Box 8109
aint Louis, Missouri 63110
ihong V. Wang
ashington University in Saint Louis
epartment of Biomedical Engineering
ptical Imaging Laboratory
ampus Box 1097
ne Brookings Drive
aint Louis, Missouri 63130-4899
Abstract. Sentinel lymph node biopsy SLNB has become the stan-
dard method of axillary staging for patients with breast cancer and
clinically negative axillae. Even though SLNB using both methylene
blue and radioactive tracers has a high identification rate, it still relies
on an invasive surgical procedure with associated morbidity. Axillary
ultrasound has emerged as a diagnostic tool to evaluate the axilla, but
it can only assess morphology and cannot specifically identify sentinel
lymph nodes SLNs. In this pilot study, we propose a noninvasive
photoacoustic SLN identification system using methylene blue injec-
tion in a rat model. We successfully image a SLN with high optical
contrast 146±41, standard deviation and good ultrasonic resolution
500 m in vivo. We also show potential feasibility for clinical
applications by imaging 20- and 31-mm-deep SLNs in 3-D and 2-D,
respectively. Our results suggest that this technology would be a use-
ful clinical tool, allowing clinicians to identify SLNs noninvasively in
vivo.
© 2008 Society of Photo-Optical Instrumentation Engineers. DOI: 10.1117/1.2976427
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entinel lymph node biopsy SLNB has recently emerged as
n accurate, less invasive alternative to axillary lymph node
issection ALND and has rapidly become the standard of
are for patients with clinically node-negative breast cancer.1,2
n SLNB, lymphatic mapping with radio-labeled sulfur col-
oid and/or blue dye is used to identify a sentinel lymph node
SLN that is most likely to contain metastatic breast cancer.
hus, the pathologic status of the axilla can be predicted, but
here are a number of practical limitations to SLNB. First,
ublished SLNB identification rates are between 90 to 95%,
nd the sensitivity of SLNB is between 88 to 95% in experi-
nced hands.1–3 This limitation results in persistent axillary
isease in about 5 to 10% of breast cancer patients, represent-
ng the false negative rate. Second, SLNB is often performed
s a staged procedure, requiring that breast cancer patients
ndergo two or more operations for definitive staging and the
reatment of the axilla. Such patients include those who have
ode-positive disease by SLNB and require complete ALND,
hose who require axillary staging prior to breast reconstruc-
ion, and those who are undergoing neoadjuvant chemo-
herapy. These clinical scenarios represent up to 40 to 50% of
atients treated for breast cancer. Last, although SLNB is
learly less invasive than ALND, it is not without morbidity.
ddress all correspondence to Lihong V. Wang, Washington University in Saint
ouis, Department of Biomedical Engineering, Optical Imaging Laboratory,
ampus Box 1097, One Brookings Drive, Saint Louis, Missouri 63130-4899,
-mail: lhwang@biomed.wustl.eduournal of Biomedical Optics 054033-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of UseA recent randomized prospective trial of SLNB versus ALND
confirms that complications of SLNB include seroma forma-
tion, lymphedema, sensory nerve injury, and limitation in
range of motion.4 These limitations of SLNB strongly suggest
that alternative strategies to stage the axilla should be
explored.
Several reports suggest that axillary ultrasound AUS is a
potentially valuable technique for identifying axillary
metastases.5–7 AUS permits the visualization of lymph node
size, shape, contour, and changes in cortical morphology and
texture that appear to be associated with the presence of axil-
lary metastases. However, sonographic signs of metastatic
disease may overlap with those of benign reactive changes,
limiting the ability of this modality alone to stage the axilla
accurately. Therefore, an imaging modality that could accu-
rately identify a SLN in vivo would allow noninvasive axil-
lary staging, with either percutaneous fine needle aspiration
biopsy FNAB or other emerging molecular techniques.
Toward this goal, an in vivo photoacoustic PA imaging
modality is proposed to identify a SLN accurately, where me-
thylene blue is accumulated, in a rat model. PA imaging is
based on the generation of PA waves by safely depositing
short-pulsed optical energy into tissue. Deposited energy
causes thermoelastic expansion and generates PA waves.8–10
PA imaging is a hybrid technology retaining high optical con-
trast while overcoming the poor spatial resolution of pure op-
tical imaging and providing good spatial resolution by detect-
1083-3668/2008/135/054033/6/$25.00 © 2008 SPIESeptember/October 2008  Vol. 1351
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Downloaded Frong ultrasound, which has relatively low scattering.11,12 The
esult of this research suggests that this PA technique may
rovide an alternative method to localize a SLN accurately.
Materials and Methods
.1 Photoacoustic Imaging
reflection-mode photoacoustic PA imaging system Fig. 1
as used for identifying a SLN following methylene blue
njection. This imaging system employed a dark-field ring-
haped illumination.13 By reducing the surface PA wave gen-
ration, this illumination allows more efficient detection of PA
aves from the deep regions, compared with a bright field
ne. The surface PA waves can interfere with those from
eeper regions and obstruct their detection.13,14 The dark-field
llumination was formed by a concave lens, a spherical coni-
al lens, and an optical condenser arranged on an optical rail
n tandem. To deliver high optical energy to a deeply located
LN, we used two prisms mounted on an xy linear translation
tage instead of an optical fiber, which has lower damage
hreshold.
For PA excitation, a 635-nm wavelength from a pulsed
aser was chosen. This wavelength is close to that of methyl-
ne blue’s peak optical absorption 677-nm wavelength,
hich is ten times greater than hemoglobin on a per molar
asis 95% oxygenated hemoglobin.15 The light source was a
unable dye laser ND6000, Continuum, Santa Barbara, Cali-
ornia pumped by Q-switched Nd:YAG LS-2137, LOTIS
Minsk, Belarus II laser, which provides 15-ns pulse du-
ation and a 10-Hz pulse repetition rate. Laser light delivered
o the skin was sufficiently broadened by a concave lens to
onform to the maximum permissible exposure MPE limi-
ation actual fluence: 3.4 mJ /cm2, MPE: 20 mJ /cm2.16 We
hose a 635-nm wavelength, since the dye laser produces
aximum energy at this wavelength with a DCM dye.
A 3.5- or 5-MHz central frequency ultrasonic transducer
V380, V308, Panametrics-NDT, Watham, Maryland was
sed for the PA signal detection, since ultrasonic waves at
hese frequencies suffer less acoustic attenuation in tissue than
igher frequency waves. Both transducers were spherically
ocused, and had 4.95- and 2.54-cm focal lengths; 2.54- and
.91-cm-diam active elements; and 70 and 72% bandwidths
ig. 1 Schematic of a reflection-mode photoacoustic imaging system.
R, prism; CC, concave lens; CL, conical lens; OC, optical condenser;
nd UT, ultrasonic transducer.ournal of Biomedical Optics 054033-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Usebased on the full width at half maximum FWHM ampli-
tudes, respectively. Transverse resolution of the system was
estimated by 1.22f /d  is the measured central wavelength,
f is the focal length, and d is the diameter of an active ele-
ment. Thus, the 5-MHz transducer was more suited for
higher transverse resolution imaging than the 3.5-MHz one.
The 3.5-MHz transducer was appropriate for deeper imaging,
since it has a longer focal length. The spatial resolutions of
the system with the 5-MHz ultrasonic transducer at 19 mm
deep were 144 m in the axial direction and 560 m in
the transverse direction.13
To obtain 3-D PA data, raster scanning was employed us-
ing an xy linear translation stage XY-6060, Danaher Motion,
Washington, D. C.. This stage was controlled by a computer
and synchronized with the data acquisition system. A continu-
ous scan was used to shorten data-acquisition time without
signal averaging. On the other hand, a stop-and-go scan was
used to average PA signals to improve their SNR for deeper
SLN imaging. The PA signal obtained along the depth direc-
tion z direction at a single point is called an A-scan. A 2-D
B-scan was acquired by a 1-D scan, and was composed of
multiple A-scans x direction. With a 2-D scan xy direc-
tions, a 3-D image was acquired. An A-scan, resolved in time
along the depth direction, was converted into a 1-D depth-
resolved image by multiplying it by the speed of sound in soft
tissues 1500 m /s.
Scanning step sizes were 0.2 and 0.4 mm for 1-D and
2-D scans, respectively. With 0.1- and 0.2-mm step sizes and
a 10-Hz pulse-repetition-frequency laser system, the acquisi-
tion time was 25 sec for a B-scan and 42 min for a 3-D
image, covering a 2020-mm field of view. The transducer
scanned an object through a 55-cm opening sealed with a
thin, clear membrane in a water container. The opening was
located on the bottom of the water container. Ultrasonic gel
was used between the clear membrane and the object to
couple the ultrasound.
Following amplification by an amplifier 5072PR,
Panametrics-NDT, PA signals were digitized by an oscillo-
scope TDS 5054, Tektronix, Natham, Massachusetts with a
50 mega-sampling rate. Since the laser system has pulse-to-
pulse fluctuations in energy, PA signals were compensated by
the signals from the photodiodes DET110, Thorlabs, newton,
New Jersey, which sample the energy of each laser pulse.
2.2 Samples
Two types of phantom experiments were performed to assess
the device’s sensitivity and estimate in vivo and ex vivo the
concentration of methylene blue accumulated in a SLN. The
PA signal from a SLN was compared with those from phan-
toms that had known concentrations of methylene blue to
measure the concentration in the SLN. First, laboratory tubing
Dow Corning Corporation, Corning, New York with
1.47-mm inner diameter ID was placed between two layers
of chicken breast tissue, as depicted in Fig. 2b. The tubing
was filled with methylene blue of concentrations ranging from
0.1 to 1%, in 0.1% increments. The top tissue layer was 12
and 20 mm thick in two consecutive sets of measurements.
The effective attenuation coefficient of chicken breast tissue is
0.9 cm−1 at the 635-nm wavelength, similar to that of hu-
man breast tissue.17,18 PA signals were measured from meth-September/October 2008  Vol. 1352
: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
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Downloaded Frolene blue within the tubing. Before measurement of PA sig-
als at each concentration, the tubing was cleaned with 0.9%
aline to remove residual dye. To estimate the in vivo concen-
ration of methylene blue, the PA signal from an in vivo SLN
as compared with that from this phantom experiment. Sec-
nd, similar to the first case, pseudolymph nodes of compa-
able dimensions were made of porcine gelatin mixed with
ethylene blue of various concentrations 0.009 to 0.7%.
he pseudolymph node experiments were performed to esti-
ate the concentration of the dye from an excised SLN
x vivo. These pseudolymph nodes were cylinders 3 mm in
iameter and 4 mm in length, similar to the dimensions of a
at SLN. PA signals were directly measured from these
seudolymph nodes Fig. 3b. The PA signal from the ex-
ised SLN was compared with those from the pseudolymph
odes to estimate the dye concentration. By using comparable
imensions, the effect of the size of the optical absorber was
uled out.
.3 Animal and Drug Information
ll animal experiments were carried out in compliance with
he guidelines on the care and the use of laboratory animals at
ashington University in Saint Louis. Adult male Sprague
awley rats weighing 250 to 350 g were used. The rat was
nitially anesthetized with a mixture of ketamine 85 mg /kg
nd xylazine 15 mg /kg. Before imaging, the hair on the
egion of interest was gently removed using a commercial
air-removal lotion. Intradermal injection of 0.07 ml of 1%
ethylene blue 10 mg /mL, American Regent, Incorporated
as performed on a left forepaw pad. After administration of
ethylene blue, photoacoustic images were acquired. During
ll image acquisitions, anesthesia was maintained using va-
orized isoflurane 1-L /min oxygen and 0.75% isoflurane,
uthanex Corporation, Shirley, New York, and vitals were
onitored using a pulse oximeter 8600V Nonin Medical In-
orporated, Plymouth, Minnesota. During image acquisition,
ig. 2 a Amplitude of photoacoustic signal versus concentration of
ethylene blue dye at 12- and 20-mm depth in chicken breast tissue,
espectively. b Experimental setup for sensitivity measurement and
n vivo estimation of concentration. c Estimation of concentration at
- to 20-mm depth. UT, ultrasonic transducer; and WC, water
ontainer.ournal of Biomedical Optics 054033-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Use8 ml of 0.9% saline was administered for hydration. After
image acquisition, the animal was euthanized by pentobarbital
overdose.
3 Results
3.1 Sensitivity of the System
An imaging system with high sensitivity is required to detect
low concentrations of methylene blue accumulated in a SLN
located deep below the skin surface. The sensitivity of the
photoacoustic PA imaging system was obtained from the
chicken tissue phantom experiments. Figure 2a shows the
peak PA signal amplitude versus methylene blue concentra-
tion at 12- and 20-mm depths, respectively. The detection
limit of the system was calculated to be 0.07 mV three
times the standard deviation of the photoacoustic signal with-
out the dye at 20 mm. This voltage corresponds to a 0.009%
concentration based on the extrapolation of the 20-mm curve
in Fig. 2a. Therefore, the imaging system is expected to be
able to detect a SLN containing greater than 0.009%
0.28-mM methylene blue located 20 mm from the skin sur-
face. However, the depth capability of the system is not
limited to 20 mm deep.
3.2 Concentration Estimation in Vivo and ex Vivo
To identify a SLN from a group of lymph nodes, it is neces-
sary to measure the concentration of methylene blue accumu-
lated within the SLN. in vivo concentration within a SLN can
be estimated by measuring a PA signal from the SLN and
reading the concentration corresponding to the measured PA
signal in Fig. 2a at the 12- and 20-mm depth. Since the
amplitudes of PA signals are proportional to optical fluence in
a medium, and the fluence between two depths can be esti-
mated based on the diffusion equation,19 the amplitudes of PA
signals for other depths were interpolated using the diffusion
equation for all concentrations of methylene blue. Interpolated
values were plotted in mesh Fig. 2c. The imaging depth
Fig. 3 A Amplitude of photoacoustic signal versus concentration of
methylene blue dye at a pseudolymph node. B Setup for ex-vivo
estimation of concentration. C Photoacoustic B-scans of the phan-
tom, the dyed SLN, and the normal SLN. The concentration in the
phantom is 0.07%, and the dyed SLN was estimated to be the same
concentration. D Photographs of SLNs with left and without right
dye deposit. ultrasonic transducer, UG: ultrasonic gel, and Wc: Water
container.September/October 2008  Vol. 1353
: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
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Downloaded Fro18 mm was demonstrated by placing two layers of
hicken breast tissue on top of the axillary surface of the rat in
ivo. At this depth, the peak amplitude of the PA signal from
he SLN was 0.30.008 mV standard error, correspond-
ng to 0.07%0.05% 2.2 mM, standard error methylene
lue Fig. 2c. For concentrations below 0.1% in Fig. 2b,
he amplitudes of the PA signals were extrapolated based on
he diffusion equation.
After all in vivo PA images of the rat SLN were acquired,
he SLN was excised to measure the PA signal more accu-
ately. The peak amplitude of the PA signal, which was ac-
uired using the method depicted in Fig. 3b, was
170.09 mV standard error. This voltage corresponds to
0.07%0.0006% standard error methylene blue Fig.
a, which is equivalent to the in vivo estimation at 18-mm
epth. These results show that the imaging system has high
ensitivity and accuracy in identifying a SLN and in estimat-
ng its dye content both in vivo and ex vivo. Figure 3c
hows the PA B-scans of the pseudolymph node, the dyed
LN, and the normal SLN. The pseudolymph node in Fig.
c “Phantom,” had a concentration of 0.07%, equivalent
o that of the dyed SLN in Fig. 3c “Dyed SLN.” Therefore,
oth the pseudolymph node and the dyed SLN have PA sig-
als of the same amplitude. By contrast, the normal SLN did
ot generate a PA signal, showing that this did not exhibit
ptical contrast. Figure 3d shows photographs of a dyed
LN and a normal SLN, respectively. Should this technology
e accepted clinically, the average concentration in a SLN can
e measured and used for SLN identification.
.3 Sentinel Lymph Node Imaging in a Rat in Vivo
rat SLN was clearly imaged by noninvasive in vivo PA
maging. Figure 4a is a photograph of a rat taken prior to
mage acquisition and after hair removal of the axillary sur-
ace; Fig. 4b is a photograph of the same rat with the skin
emoved after PA imaging. The SLN is unclear in the photo-
raph because it is surrounded by fatty tissue. Before methyl-
ne blue injection, a PA control image was obtained, and is
hown in the form of a maximum amplitude projection
MAP Fig. 4c.20 The vasculature near an axial node was
learly imaged with high contrast 517, standard deviation
ith respect to the background and good resolution
500 m. Since methylene blue molecules are small
0.7 nm in diameter and 1.6 nm in length21 and migrate into
SLN quickly, scanning started immediately after administra-
ion of methylene blue. The SLN appeared at the left top
orner with a much higher contrast 14641, standard devia-
ion with respect to the background than the surrounding
lood vessels Fig. 4d, since methylene blue has higher
ptical absorption than blood at the 635-nm wavelength. The
ontrast of the SLN with respect to the blood vessel was 2.
he signal amplitude of the surrounding blood vessels was
lso increased by 19%3% compared to that in the con-
rol image, since some of methylene blue flowed into the
lood stream directly and/or through the SLN. Accordingly,
ptical absorption in blood was increased. In all PA images,
he brighter the object, the higher the absorption. Another PA
mage was acquired at 50 min after dye injection with the
can head repositioned Fig. 4e. The SLN was still ob-
erved. In humans, the mean depth of SLNs is 125 mmournal of Biomedical Optics 054033-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Usestandard deviation, from the SLN’s top surface to the skin
surface unpublished data, To check the feasibility of this
imaging depth, chicken breast tissue was placed on top of the
axillary surface of the rat, and then a PA image was obtained
Fig. 4f. The demonstrated imaging depth was 18 mm.
Since methylene blue accumulated in the SLN still had higher
absorption than the nearby blood vessels, the SLN is domi-
nant in the PA image, while the blood vessels have faded
away. Figure 4g shows an image of B-scans along the dotted
line in Fig. 4e, showing the depth of the SLN. A 3-D volu-
metric image was also constructed Fig. 4h. In some clini-
cal cases, the depth of a SLN is greater than 18 mm
185 mm, standard deviation, from the SLN’s bottom sur-
face to the skin surface. To increase imaging depth as well as
SNR, higher incident energy of a laser is necessary for the PA
Fig. 4 Noninvasive in vivo photoacoustic MAP images of the SLN in a
rat. A Photograph with hair removed before photoacoustic imaging.
B Photograph with skin removed after photoacoustic imaging. C
Control photoacoustic image without methylene blue injection. Bright
parts represent optical absorption, here, blood vessels. x and y denote
B-scan and 3-D imaging. D After-injection photoacoustic image. E
After-injection photoacoustic MAP image 52 min after injection
with the scan head repositioned. F Photoacoustic MAP image of
18-mm-deep SLN. Chicken breast tissue was placed on top of the
axillary surface of the rat. G Photoacoustic B-scan image corre-
sponding to the dotted line in E, showing the depth of the SLN. The
vertical axis in this image corresponds to depth. H Photoacoustic
3-D volumetric visualization. The color bars represent optical absorp-
tion. C and D have the same color bar range as E. Color online
only.September/October 2008  Vol. 1354
: http://spiedigitallibrary.org/ss/TermsOfUse.aspx
e
t
t
P
c
3
P
s
f
i
t
b
b
r
F
r
d
r
o
s
s
t
l
w
t

F
a
i
M
c
i
i
a
Song et al.: Noninvasive photoacoustic identification of sentinel lymph nodes…
J
Downloaded Froxcitation, while still staying within the MPE. We note that in
his study, the incident fluence of the laser was five times less
han the MPE, so increasing the laser fluence can enhance the
A signal by five times.
Accordingly, in vivo PA SLN imaging of another rat was
onducted with twice the incident optical fluence. The
.5-MHz central frequency ultrasonic transducer V380,
anametrics-NDT was employed instead of the 5-MHz one,
ince the former has a longer focal length and is more suitable
or deeper SLN identification. Figure 5a is the PA control
mage before injection of methylene blue, showing vascula-
ure in the skin. Figure 5b reveals the SLN after methylene
lue injection. For demonstration at a greater depth, chicken
reast tissue about 18 mm thick was placed on the axillary
egion. Figure 5c is an 20-mm-deep PA SLN image. In
ig. 5c, the contrasts of the SLN and the blood vessel with
espect to the background were 24.53.3 and 132.3 stan-
ard deviation, respectively. The contrast of the SLN with
espect to the blood vessel was 0.9. Figure 5d is an image
f B-scans acquired along the far-right dotted line in Fig. 5c,
howing the depth of the SLN. Here, the skin surface is not
hown due to the limited record length of the acquisition sys-
em. We further tried deeper SLN imaging by adding a second
ayer of chicken breast tissue. Three B-scan images Fig. 5e
ere obtained at three locations of the SLN area with 50
imes averaging. The total imaging depth demonstrated was
31 mm, greater than the mean depth of the SLN in humans
ig. 5 Noninvasive in vivo photoacoustic MAP images of the SLN in
nother rat. A Control photoacoustic image without methylene blue
njection. B After-injection photoacoustic image. C Photoacoustic
AP image of 20-mm-deep SLN. D Photoacoustic B-scan image
orresponding to the dotted line d in C. E Photoacoustic B-scan
mages acquired at three different locations a, b, c in C. Total
maging depth was 31 mm. For this depth, the 3.5-MHz transducer
nd 50 times averaging were employed.ournal of Biomedical Optics 054033-
m: http://biomedicaloptics.spiedigitallibrary.org/ on 07/06/2016 Terms of Usefrom the SLN’s bottom surface to the skin surface.
4 Discussion
Since this imaging system currently employs a 10-Hz pulse-
repetition-frequency laser and a raster scan using a focused
ultrasonic transducer, the acquisition times for B-scan and
3-D imaging are limited to about 25 sec with a 100-m step
size and 42 min with a 200-m step size, respectively. There-
fore, employing a higher pulse-repetition-frequency laser, say
50 Hz, and an ultrasound array system can accelerate acqui-
sition, allowing potentially real-time photoacoustic PA im-
aging. The acquisition time can also be reduced by increasing
the step sizes. Except for Fig. 5e, the PA signals were not
averaged to shorten the scanning time. With the availability of
an ultrasound array system and a higher pulse-repetition-
frequency laser, signal averaging can be implemented within a
reasonable time frame to improve SNR. In current SLNB
practice, two or more surgeries are necessary for the definitive
staging and treatment of the axilla. Furthermore, common side
effects may be experienced by the patient as previously de-
scribed. Since PA SLN identification is totally noninvasive
and safe, it has potential future applications in the identifica-
tion of SLNs in vivo in clinical practice, thus reducing patient
morbidity.
In conclusion, the feasibility of noninvasive SLN identifi-
cation based on methylene blue injection in an animal model
was demonstrated with in vivo PA imaging. The proposed
imaging system was proven to be highly sensitive 0.28 mM
to methylene blue and suitable to estimate the dye concentra-
tion accumulated within a SLN both in vivo and ex vivo with
high optical contrast and good ultrasonic resolution. In addi-
tion, a SLN can be located in the x, y, and z directions. With
these features, the proposed PA imaging technology offers a
potentially minimally invasive method of SLN identification.
Future studies may be directed toward the diagnostic sam-
pling of PA-localized SLNs using either percutaneous FNAB
and/or molecular techniques, potentially eliminating the need
for invasive axillary staging procedures.
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